Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT00866697 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

940

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Pazopanib
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals

Collaborators

[object Object]